noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Rezolute Inc.

Single Dose Studies of RZ358 in Patients with Congenital[...]
Rezolute Inc.

Continuous Glucose Monitoring (CGM) Reveals Undertreated Hypoglycemia[...]
Rezolute Inc.

Phase 2b RIZE Data Presentation by Hüseyin Demirbilek, M.D. at ESPE 2022

Healthcare

Results

Rezolute Inc.

03/02/2015 | Press release | Archived content

XOMA 358, a Novel Treatment for Hyperinsulinemic Hypoglycemia: Safety and Clinical Pharmacology from the First in Human Trial

Sharing and Personal Tools

Please select the service you want to use: